ATE34770T1 - Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie. - Google Patents

Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie.

Info

Publication number
ATE34770T1
ATE34770T1 AT84301997T AT84301997T ATE34770T1 AT E34770 T1 ATE34770 T1 AT E34770T1 AT 84301997 T AT84301997 T AT 84301997T AT 84301997 T AT84301997 T AT 84301997T AT E34770 T1 ATE34770 T1 AT E34770T1
Authority
AT
Austria
Prior art keywords
replication
origin
copy number
promoter
takes place
Prior art date
Application number
AT84301997T
Other languages
English (en)
Inventor
Geoffrey Thomas Yarranton
Gwynfor Owen Humphreys
Martyn Kim Robinson
Celia Ann Caulcott
Edwina Mary Wright
Original Assignee
Celltech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech Ltd filed Critical Celltech Ltd
Application granted granted Critical
Publication of ATE34770T1 publication Critical patent/ATE34770T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT84301997T 1983-03-25 1984-03-23 Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie. ATE34770T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838308236A GB8308236D0 (en) 1983-03-25 1983-03-25 Dna vectors
EP84301997A EP0121386B1 (de) 1983-03-25 1984-03-23 DNA-Vektoren und ihre Verwendung in der rekombinanten DNA-Technologie

Publications (1)

Publication Number Publication Date
ATE34770T1 true ATE34770T1 (de) 1988-06-15

Family

ID=10540205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84301997T ATE34770T1 (de) 1983-03-25 1984-03-23 Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie.

Country Status (8)

Country Link
US (1) US5015573A (de)
EP (1) EP0121386B1 (de)
JP (2) JPH0634721B2 (de)
AT (1) ATE34770T1 (de)
AU (1) AU565352B2 (de)
DE (2) DE3471688D1 (de)
GB (2) GB8308236D0 (de)
WO (1) WO1984003713A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201116B (en) * 1982-09-16 1990-09-28 Benzon As Alfred Process for producing plasmids having uncontrolled replication conduct under given circumstances
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
HU194307B (en) * 1983-09-16 1988-01-28 Richter Gedeon Vegyeszet Process for producing plasmidvectors of high copy number
WO1988006186A2 (en) * 1987-02-19 1988-08-25 The Upjohn Company cDNAs ENCODING SOMATOTROPIN, EXPRESSION VECTORS AND HOSTS
US5240837A (en) * 1987-02-19 1993-08-31 The Upjohn Company CDNAS encoding somatotropin, expression vectors and hosts
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
US4966841A (en) * 1987-05-22 1990-10-30 The Board Of Regents Of The University Of Washington Enhanced vector production and expression of recombinant DNA products
DE3853481T2 (de) * 1987-09-09 1995-10-19 Celltech Therapeutics Ltd Fv Antikörperfragment-Herstellung.
GB8819135D0 (en) * 1988-08-11 1988-09-14 Celltech Ltd Tryptophan production
FI88309C (fi) * 1989-04-20 1993-04-26 Bio Orbit Oy Ny biotest
GB9215541D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
GB9215540D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
GB9215550D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US6743780B1 (en) 1995-09-08 2004-06-01 Cobra Biologics Limited Plasmid stabilization
GB9518395D0 (en) * 1995-09-08 1995-11-08 Therexsys Ltd Plasmid stabilization
JP3549210B2 (ja) 1996-03-13 2004-08-04 タカラバイオ株式会社 プラスミド
US6747129B1 (en) * 1998-09-15 2004-06-08 The Regents Of The University Of California Target of RNAIII activating protein(TRAP)
AU1031900A (en) * 1998-11-09 2000-05-29 Genecare Development Aps Novel plasmids for use in medicine and method of producing same
US6780405B1 (en) * 2000-04-28 2004-08-24 Avant Immunotherapeutics, Inc. Regulated antigen delivery system (RADS)
US7575924B2 (en) 2000-11-13 2009-08-18 Research Development Foundation Methods and compositions relating to improved lentiviral vectors and their applications
US20040137003A1 (en) * 2001-04-30 2004-07-15 Curtiss Iii Roy Regulated antigen delivery system (rads)
WO2003012054A2 (en) 2001-08-02 2003-02-13 Institut Clayton De La Recherche Methods and compositions relating to improved lentiviral vector production systems
CN1606456A (zh) 2001-10-02 2005-04-13 克雷顿研究院 限制性表达慢病毒载体
CN1759182A (zh) * 2002-11-22 2006-04-12 克雷顿研究院 调节基因的组合物和系统
DE602004029868D1 (de) * 2003-03-05 2010-12-16 Chemo Sero Therapeut Res Inst Verfahren zur herstellung eines heterologen proteins in e. coli
US7794971B1 (en) 2003-07-01 2010-09-14 Epicentre Technologies Corporation Compositions and methods for controlling copy number for a broad range of plasmids and uses thereof
KR100760596B1 (ko) * 2003-09-11 2007-09-20 가부시키가이샤 아드반테스트 오차 보정 신호 생성 장치 및 이 오차 보정 신호 생성장치를 구비한 직교 변조 장치
CA2554534C (en) 2004-02-04 2013-01-08 Merck & Co., Inc. Process for large scale production of plasmid dna by e. coli fermentation
US7482148B2 (en) * 2004-03-30 2009-01-27 Sudershan Biotech Ltd. Recombinant calf-chymosin and a process for producing the same
WO2006081529A2 (en) 2005-01-28 2006-08-03 Nature Technology Corp. Compositions and processes for improved plasmid dna production
US8916376B2 (en) * 2007-05-15 2014-12-23 Biotex, Inc. Metal-binding peptides
EA201591324A1 (ru) 2013-01-16 2016-01-29 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Полипептид растворимого рецептора 3 фактора роста фибробластов (fgr3) для применения с целью предотвращения или лечения нарушений, связанных с замедлением роста скелета
UY35368A (es) * 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
EP3197914B1 (de) * 2014-09-23 2024-02-07 Regeneron Pharmaceuticals, Inc. Anti-il-25-antikörper und verwendungen davon
SI3242888T1 (sl) * 2015-01-07 2021-07-30 Pfizer Inc. Topne vabe FGFR3 za zdravljenje motenj rasti skeleta
RU2751483C2 (ru) 2016-07-07 2021-07-14 Пфайзер Инк. Полипептиды, являющиеся растворимыми рецепторами 3 фактора роста фибробластов (sfgfr3), и пути их применения
BR112020018709A2 (pt) * 2018-03-28 2021-01-05 Bristol-Myers Squibb Company Proteínas de fusão do receptor alfa de interleucina-2/interleucina-2 e métodos de uso
AR116566A1 (es) 2018-10-03 2021-05-19 Novartis Ag Administración sostenida de polipéptidos similares a la angiopoyetina 3
CA3185855A1 (en) * 2020-06-05 2021-12-09 Modernatx, Inc. Bacterial strains for dna production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2759053A1 (de) * 1977-12-30 1979-07-12 Uhlin Verfahren zum herstellen von genprodukten von plasmid-dns
CA1198067A (en) * 1981-02-27 1985-12-17 David H. Gelfand Stable high copy number plasmids
CA1198069A (en) * 1982-06-08 1985-12-17 David H. Gelfand Temperature sensitive multicopy plasmids
US4806471A (en) * 1982-09-16 1989-02-21 A/S Alfred Benzon Plasmids with conditional uncontrolled replication behavior

Also Published As

Publication number Publication date
JPS60501837A (ja) 1985-10-31
DE3471688D1 (en) 1988-07-07
GB2136814A (en) 1984-09-26
EP0121386A1 (de) 1984-10-10
GB2136814B (en) 1987-05-28
EP0121386B1 (de) 1988-06-01
AU2812484A (en) 1984-10-09
JPH0634721B2 (ja) 1994-05-11
JPH06315388A (ja) 1994-11-15
JPH07114703B2 (ja) 1995-12-13
GB8308236D0 (en) 1983-05-05
GB8407572D0 (en) 1984-05-02
AU565352B2 (en) 1987-09-10
US5015573A (en) 1991-05-14
WO1984003713A1 (en) 1984-09-27
DE121386T1 (de) 1985-05-23

Similar Documents

Publication Publication Date Title
ATE34770T1 (de) Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie.
MX9606476A (es) Inhibicion citoplasmica de expresion de genes.
DK97784D0 (da) Dna-segment
WO1999043835A3 (en) Methods for producing a polypeptide in a bacillus cell
DK0770136T3 (da) Fremgangsmåde til at selektere höjtudtrykkende værtsceller
IE872455L (en) Improved recombinant expression
NO950534L (no) Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
ATE328095T1 (de) Verbesserungen des stärkegehaltes von pflanzen
DE3851399D1 (de) Transientes Expressionssystem zur Herstellung von rekombinantem Protein.
DK0864645T3 (da) Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
SE8603145L (sv) Forfarande for framstellning av interferon-beta
ES2013324A6 (es) Un metodo mejorado para producir una proteina heterologa.
DE69828193D1 (de) Hyaluronan synthase gen und seine verwendung
SG141233A1 (en) Control of gene expression
DK0663921T3 (da) Fremgangsmåde til forøgelse af ekspression og reduktion af ekspressionsvariabilitet af fremmede gener i planteceller
FI941947A0 (fi) Rekombinantti-core-streptavidiini
KR880010126A (ko) 펙틴 라이에이즈 발현 시스템을 암호화하는 dna 서열을 함유하는 재조합 dna 분자 및 이의 제조방법
DE69328514D1 (de) Herstellung rekombinanter Proteine unter Verwendung von Herpes-Virus-Promotoren und VP16-Transaktivatoren
DE69734512D1 (de) Steigerung der genexpression
KR930701610A (ko) 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학분야에서 이들을 사용하는 방법
NO924576D0 (no) Kloning og ekspresjon av gener som koder for arabinan-nedbrytende enzymer av sopp-opprinnelse
DK0843731T3 (da) Adenovirusvektorer til genterapi
DK160947C (da) Gen-udtrykkelsessystem
Schwartz Genetic studies on mutant enzymes in maize, V. in vitro interconversion of allelic isozymes
EP0232845A3 (de) Induzierbare Wärmeschock- und Amplifizierungssysteme

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time